Respiratory Infectious Disease Diagnostics Market Report – Research, Industry Analysis Reports and Market Demands

Global Respiratory Infectious Disease Diagnostics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Respiratory Infectious Disease Diagnostics Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Nucleic Acid Testing
- 1.3.3 Antigen Testing
- 1.3.4 Antibody Testing
1.4 Market Analysis by Sample
- 1.4.1 Overview: Global Respiratory Infectious Disease Diagnostics Consumption Value by Sample: 2021 Versus 2025 Versus 2032
- 1.4.2 Throat Swab
- 1.4.3 Nasal Swab
- 1.4.4 Sputum
- 1.4.5 Other
1.5 Market Analysis by Testing Type
- 1.5.1 Overview: Global Respiratory Infectious Disease Diagnostics Consumption Value by Testing Type: 2021 Versus 2025 Versus 2032
- 1.5.2 Single Detection
- 1.5.3 Multiple Detection
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Respiratory Infectious Disease Diagnostics Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals
- 1.6.3 Clinical Laboratories
- 1.6.4 Others
1.7 Global Respiratory Infectious Disease Diagnostics Market Size & Forecast
- 1.7.1 Global Respiratory Infectious Disease Diagnostics Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Respiratory Infectious Disease Diagnostics Sales Quantity (2021-2032)
- 1.7.3 Global Respiratory Infectious Disease Diagnostics Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Respiratory Infectious Disease Diagnostics by Manufacturer

3.1 Global Respiratory Infectious Disease Diagnostics Sales Quantity by Manufacturer (2021-2026)
3.2 Global Respiratory Infectious Disease Diagnostics Revenue by Manufacturer (2021-2026)
3.3 Global Respiratory Infectious Disease Diagnostics Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Respiratory Infectious Disease Diagnostics by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Respiratory Infectious Disease Diagnostics Manufacturer Market Share in 2025
- 3.4.3 Top 6 Respiratory Infectious Disease Diagnostics Manufacturer Market Share in 2025
3.5 Respiratory Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
- 3.5.1 Respiratory Infectious Disease Diagnostics Market: Region Footprint
- 3.5.2 Respiratory Infectious Disease Diagnostics Market: Company Product Type Footprint
- 3.5.3 Respiratory Infectious Disease Diagnostics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Respiratory Infectious Disease Diagnostics Market Size by Region
- 4.1.1 Global Respiratory Infectious Disease Diagnostics Sales Quantity by Region (2021-2032)
- 4.1.2 Global Respiratory Infectious Disease Diagnostics Consumption Value by Region (2021-2032)
- 4.1.3 Global Respiratory Infectious Disease Diagnostics Average Price by Region (2021-2032)
4.2 North America Respiratory Infectious Disease Diagnostics Consumption Value (2021-2032)
4.3 Europe Respiratory Infectious Disease Diagnostics Consumption Value (2021-2032)
4.4 Asia-Pacific Respiratory Infectious Disease Diagnostics Consumption Value (2021-2032)
4.5 South America Respiratory Infectious Disease Diagnostics Consumption Value (2021-2032)
4.6 Middle East & Africa Respiratory Infectious Disease Diagnostics Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
5.2 Global Respiratory Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
5.3 Global Respiratory Infectious Disease Diagnostics Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
6.2 Global Respiratory Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
6.3 Global Respiratory Infectious Disease Diagnostics Average Price by Application (2021-2032)

7 North America

7.1 North America Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
7.2 North America Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
7.3 North America Respiratory Infectious Disease Diagnostics Market Size by Country
- 7.3.1 North America Respiratory Infectious Disease Diagnostics Sales Quantity by Country (2021-2032)
- 7.3.2 North America Respiratory Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
8.2 Europe Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
8.3 Europe Respiratory Infectious Disease Diagnostics Market Size by Country
- 8.3.1 Europe Respiratory Infectious Disease Diagnostics Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Respiratory Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region
- 9.3.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Respiratory Infectious Disease Diagnostics Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
10.2 South America Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
10.3 South America Respiratory Infectious Disease Diagnostics Market Size by Country
- 10.3.1 South America Respiratory Infectious Disease Diagnostics Sales Quantity by Country (2021-2032)
- 10.3.2 South America Respiratory Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country
- 11.3.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Respiratory Infectious Disease Diagnostics Market Drivers
12.2 Respiratory Infectious Disease Diagnostics Market Restraints
12.3 Respiratory Infectious Disease Diagnostics Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Respiratory Infectious Disease Diagnostics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Respiratory Infectious Disease Diagnostics
13.3 Respiratory Infectious Disease Diagnostics Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Respiratory Infectious Disease Diagnostics Typical Distributors
14.3 Respiratory Infectious Disease Diagnostics Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Respiratory Infectious Disease Diagnostics market size was valued at US$ 8358 million in 2025 and is forecast to a readjusted size of US$ 11502 million by 2032 with a CAGR of 4.7% during review period.
Respiratory Infectious Disease Diagnostics refers to an in-vitro diagnostic product and technology system used to detect, identify, type, and clinically interpret viruses, bacteria, mycoplasma, chlamydia, and related immune-response markers in samples such as nasopharyngeal swabs, oropharyngeal swabs, nasal secretions, sputum, bronchoalveolar lavage fluid, and serum. It covers nucleic acid testing, antigen testing, antibody testing, lateral-flow immunoassays, fluorescent PCR, isothermal amplification, sequencing, multiplex panels, automated testing platforms, and laboratory information management. It is mainly used for the differential diagnosis of influenza, COVID-19, respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus, Mycoplasma pneumoniae, Chlamydia pneumoniae, and bacterial respiratory infections. Its core value lies in enabling rapid clinical triage, precise medication, infection control, severe-case early warning, and public health surveillance, making it a critical infrastructure linking clinical efficiency with infectious disease control capability.In 2025, global Respiratory Infectious Disease Diagnostics production reached approximately 1430.87 m units, with an average global market price of around US$ 5.68 perunit.The average gross profit margin of this product is 55%.
Respiratory infectious disease diagnostics is shifting from emergency testing during the pandemic toward a long-term market driven by routine use, seasonality, multiplex pathogen detection, and clinical pathway integration. Influenza, COVID-19, respiratory syncytial virus, Mycoplasma pneumoniae, human metapneumovirus, adenovirus, and other pathogens show alternating prevalence, mixed infections, and population-specific differences, making symptom-based differentiation insufficient for rapid diagnosis. This drives hospitals, public health agencies, independent clinical laboratories, and primary healthcare institutions to continuously strengthen precise testing capabilities. Corporate annual reports show that global diagnostic leaders have incorporated respiratory pathogen testing into their core molecular and rapid diagnostic portfolios, while government public health systems continue to strengthen sentinel surveillance, fever clinics, infectious disease departments, and laboratory testing capacity. Multiplex panels, rapid turnaround, automation-platform compatibility, and scenario expansion from hospital diagnosis to regional surveillance will become important drivers for industry value reassessment.The key challenges in respiratory infectious disease diagnostics come from pathogen prevalence fluctuations, pricing pressure, regulatory access requirements, technology iteration, and product homogenization. After the pandemic, demand for single-pathogen testing has returned to a more normalized level, requiring companies to shift toward syndromic diagnosis covering influenza, RSV, mycoplasma, bacteria, and viral combinations. Nucleic acid testing requires high sensitivity, specificity, contamination control, and laboratory workflow capability, while antigen and rapid testing must balance speed, cost, sample adaptability, and accuracy. Because respiratory infections are highly seasonal and sometimes sudden, companies also face pressure in capacity planning, inventory management, channel response, and stable raw-material supply. Future competition will not be limited to price, but will depend on clinical evidence, test menus, platform compatibility, supply-chain resilience, and public health response capability.Downstream demand is moving from “whether testing is available” to “whether multiple pathogens can be rapidly and accurately distinguished in a single workflow.” Emergency departments, pediatrics, respiratory medicine, infectious disease departments, and intensive care units in large hospitals need rapid triage and precise medication support to shorten diagnostic time, reduce empirical anti-infective therapy, and optimize ward management. Primary healthcare institutions focus more on rapid tests that are easy to operate, intuitive in results, and short in turnaround time for the initial screening of fever, cough, and influenza-like cases. Independent clinical laboratories emphasize batch testing and automated workflows, while public health systems focus on pathogen-spectrum monitoring, regional epidemic trends, and early warning. As tiered diagnosis, infection control, and infectious disease surveillance systems improve, respiratory infectious disease diagnostics will become a key link among hospital diagnosis, primary screening, and public health control.
This report is a detailed and comprehensive analysis for global Respiratory Infectious Disease Diagnostics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Respiratory Infectious Disease Diagnostics market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Respiratory Infectious Disease Diagnostics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Respiratory Infectious Disease Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Respiratory Infectious Disease Diagnostics market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Respiratory Infectious Disease Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Respiratory Infectious Disease Diagnostics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Abbott, bioMérieux, Qingdao Hightop Biotec, Roche, QuidelOrtho, Thermo Fisher Scientific, Sansure, BD, Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Respiratory Infectious Disease Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nucleic Acid Testing
Antigen Testing
Antibody Testing
Market segment by Sample
Throat Swab
Nasal Swab
Sputum
Other
Market segment by Testing Type
Single Detection
Multiple Detection
Market segment by Application
Hospitals
Clinical Laboratories
Others
Major players covered
Danaher
Abbott
bioMérieux
Qingdao Hightop Biotec
Roche
QuidelOrtho
Thermo Fisher Scientific
Sansure
BD
Hologic
Innovita
DiaSorin
Wondfo Biotech
Autobio
Siemens Healthineers
Bio-germ
Wuhan Easy Diagnosis
Daan Gene
BioPerfectus
Hybribio
Liferiver
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Respiratory Infectious Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Respiratory Infectious Disease Diagnostics, with price, sales quantity, revenue, and global market share of Respiratory Infectious Disease Diagnostics from 2021 to 2026.
Chapter 3, the Respiratory Infectious Disease Diagnostics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Respiratory Infectious Disease Diagnostics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Respiratory Infectious Disease Diagnostics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Respiratory Infectious Disease Diagnostics.
Chapter 14 and 15, to describe Respiratory Infectious Disease Diagnostics sales channel, distributors, customers, research findings and conclusion.

Buy now